CD36 and type 2 diabetes mellitus: Previously, our genome-wide PrediXcan analysis (GWA) of data from Vanderbilt BioVu patient biobank associated low CD36 expression in muscle/heart, and a SNP (rs17236824) close to the transcription start site, with renal, ophthalmic and neurological complications of type 2 diabetes [14].